A Dutch court has ruled that billionaire and vaccine advocate Bill Gates must stand trial in the Netherlands for allegedly misleading the public about the safety of COVID-19 vaccines during the pandemic.
The ruling, announced on Wednesday, follows a lawsuit filed by seven plaintiffs who claim to have suffered injuries from the vaccines.
The plaintiffs allege that Gates, along with former Dutch Prime Minister and current NATO Secretary General Mark Rutte, Pfizer CEO Albert Bourla, and members of the Dutch government’s COVID-19 Outbreak Management Team, misled the public regarding the vaccines’ safety.
According to Dutch newspaper De Telegraaf, the lawsuit was filed last year, with Gates named as one of the “experts” making several claims about the COVID experimental vaccines.
The plaintiffs argue that Gates, through his involvement with the Bill & Melinda Gates Foundation and the World Economic Forum (WEF), was part of an agenda referred to as “The Great Reset Project.”
READ ALSO: New COVID-19 Variant XEC Rapidly Spreading Across Europe, US
They claim this initiative aimed to exploit the global crisis to implement significant societal changes under the guise of combating the pandemic, including promoting vaccines that were allegedly known to be unsafe.
The lawsuit alleges that the plaintiffs were deceived into receiving what they describe as dangerous injections, resulting in severe physical and mental injuries. They assert that Gates made false statements regarding the vaccines, including claims that they would stop transmission, prevent illness, and eliminate the need for masks.
One of the original seven plaintiffs has reportedly died since the lawsuit was filed, leaving six to continue the case against Gates and others.
The court had ordered Gates to pay the plaintiffs’ legal fees amounting to €1,406.00 ($1,518.44) within 14 days or face further penalties. A new hearing is scheduled for November 27, 2024.
In a 2020 article, Gates cautioned that creating a COVID-19 vaccine is just part of the challenge.
He stated, “We aren’t sure which vaccines will be the most effective yet, and each requires unique technology to make. That means nations need to invest in many different kinds of manufacturing facilities now, knowing that some will never be used. Otherwise, we’ll waste months after the lab develops an immunisation, waiting for the right manufacturer to scale up.”
